These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
696 related articles for article (PubMed ID: 26388691)
21. Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting. Pandey S; Vijayendra Swamy SM; Ubaid Ulla UM; Gupta A; Patel H; Yadav JS Curr Drug Deliv; 2017 Sep; 14(6):887-899. PubMed ID: 27538461 [TBL] [Abstract][Full Text] [Related]
22. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Feng SS; Mei L; Anitha P; Gan CW; Zhou W Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012 [TBL] [Abstract][Full Text] [Related]
23. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound. Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431 [TBL] [Abstract][Full Text] [Related]
24. Amine-functionalized poly(lactic-co-glycolic acid) nanoparticles for improved cellular uptake and tumor penetration. Lee SY; Cho HJ Colloids Surf B Biointerfaces; 2016 Dec; 148():85-94. PubMed ID: 27591574 [TBL] [Abstract][Full Text] [Related]
25. Local delivery of controlled-release simvastatin/PLGA/HAp microspheres enhances bone repair. Tai IC; Fu YC; Wang CK; Chang JK; Ho ML Int J Nanomedicine; 2013; 8():3895-904. PubMed ID: 24143094 [TBL] [Abstract][Full Text] [Related]
26. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles. Lee C; Seo J; Hwang HS; Thao LQ; Lee S; Lee ES; Lee EH; Choi HG; Youn YS Biomed Pharmacother; 2016 Mar; 78():226-233. PubMed ID: 26898446 [TBL] [Abstract][Full Text] [Related]
27. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Rafiei P; Haddadi A Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163 [TBL] [Abstract][Full Text] [Related]
28. Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo. Qiao C; Zhang K; Jin H; Miao L; Shi C; Liu X; Yuan A; Liu J; Li D; Zheng C; Zhang G; Li X; Yang B; Sun H Int J Nanomedicine; 2013; 8():2985-95. PubMed ID: 23990717 [TBL] [Abstract][Full Text] [Related]
29. Novel PLGA-based nanoparticles for the oral delivery of insulin. Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248 [TBL] [Abstract][Full Text] [Related]
30. Estradiol-loaded PLGA nanoparticles for improving low bone mineral density of cancellous bone caused by osteoporosis: Application of enhanced charged nanoparticles with iontophoresis. Takeuchi I; Kobayashi S; Hida Y; Makino K Colloids Surf B Biointerfaces; 2017 Jul; 155():35-40. PubMed ID: 28391082 [TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy. Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991 [TBL] [Abstract][Full Text] [Related]
32. Preparation, characterization, and in vivo study of rhein-loaded poly(lactic-co-glycolic acid) nanoparticles for oral delivery. Yuan Z; Gu X Drug Des Devel Ther; 2015; 9():2301-9. PubMed ID: 25960633 [TBL] [Abstract][Full Text] [Related]
33. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency. Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112 [TBL] [Abstract][Full Text] [Related]
34. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles. Yang Y; Xie XY; Mei XG Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204 [TBL] [Abstract][Full Text] [Related]
35. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin. Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909 [TBL] [Abstract][Full Text] [Related]
36. Polysorbate 80-coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain-protective effects in rats. Sun D; Xue A; Zhang B; Lou H; Shi H; Zhang X J Pharm Pharmacol; 2015 Dec; 67(12):1650-62. PubMed ID: 26407669 [TBL] [Abstract][Full Text] [Related]
37. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery. Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897 [TBL] [Abstract][Full Text] [Related]
38. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery. Park JH; Lee JY; Termsarasab U; Yoon IS; Ko SH; Shim JS; Cho HJ; Kim DD Int J Pharm; 2014 Oct; 473(1-2):426-33. PubMed ID: 25079433 [TBL] [Abstract][Full Text] [Related]
39. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice. Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924 [TBL] [Abstract][Full Text] [Related]
40. In vitro degradation of poly (D, L-lactide-co-glycolide) nanoparticles loaded with linamarin. Hussein AS; Abdullah N; Ahmadun FR IET Nanobiotechnol; 2013 Jun; 7(2):33-41. PubMed ID: 24046903 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]